Introduction
Elaboration of how HIV-1 protease recognizes its endogenous substrates has been a triumph of structural biology (Prabu-Jeyabalan et al., 2002 Liu et al., 2011; Tie et al., 2005) . The homodimeric protease is known to bind peptidic substrates between its core and flaps through the formation of a mixed -sheet-like motif. The conserved interactions with the main chain diminish the reliance on substrate side chains for recognition. The side chains of bound substrates are buried in subsites ( Fig. 1a ) through hydrophobic and nonconserved hydrogen-bonding interactions. Accordingly, HIV-1 protease substrates lack a rigid consensus sequence (Table 1) . This variability could provide spatial and temporal regulation of proteolytic processing (Lee et al., 2012) .
Endogenous substrates exhibit a modest affinity for HIV-1 protease, having K m values in the millimolar to highmicromolar range. Despite extensive efforts, few good substrates for HIV-1 protease have emerged from rational design (Altman et al., 2008) . In contrast, directed evolution has generated excellent substrates (Beck et al., 2000; Szeltner & Polgá r, 1996) . In previous work, we employed a substrate for HIV-1 protease with a low micromolar K m value, SGIFLETS, as the basis for a hypersensitive assay of catalytic activity (Windsor & Raines, 2015) . Here, we report the high-resolution X-ray crystal structure of the complex of this substrate with an inactivated protease variant.
Materials and methods

Protein
The expression plasmid for D25N HIV-1 protease was prepared as described previously (Windsor & Raines, 2015) with modifications. An initiating methionine codon was placed directly before the native N-terminal proline residue, and an AAC codon was used for residue 25. D25N HIV protease was produced heterologously in Escherichia coli cells grown in Luria-Bertani medium. Expression was induced when the OD reached 1.5 at 600 nm, and the cells were grown for an additional 4 h. The cell pellets were suspended in 20 mM Tris-HCl buffer pH 7.4 containing 1 mM EDTA, lysed using a cell disrupter from Constant Systems and collected by centrifugation at 10 500g for 30 min. The cell pellet was dissolved in 20 mM Tris-HCl buffer pH 8.0 containing 9 M urea and the solution was clarified by centrifugation at 30 000g for 1 h. The supernatant was flowed through a 0.2 mm filter and a HiTrap Q column from GE Healthcare, which removed anionic contaminants (Velazquez-Campoy et al., 2001) . To fold the protease, the resulting solution was diluted 20-fold by dropwise addition to 50 mM sodium acetate buffer pH 5.0 containing 100 mM NaCl, 5%(v/v) ethylene glycol and 10%(v/v) glycerol. The solution of folded protease was concentrated using a stirred-cell concentrator from Amicon and applied onto a G75 gel-filtration chromatography column (GE Healthcare) that had been equilibrated with the folding buffer. The protease, which eluted near 0.5 column volumes, was concentrated to 10 mg ml À1 . The purity of the ensuing protein was verified by SDS-PAGE.
Peptide
The SGIFLETS peptide with free N-and C-termini was synthesized and purified to >99% purity by Biomatik, Wilmington, Delaware, USA. Stock solutions in DMSO containing 0.1%(v/v) TFA were prepared at a concentration of 1 mM for crystallization.
Crystallization
Protease and peptide stock solutions were mixed in a 4:1 volume ratio. Crystals were grown by vapor diffusion in 2 ml drops over a mother liquor consisting of 100 mM sodium acetate buffer pH 5.0 containing 1.0 M NaCl. The crystals, which grew within 24 h, were cryoprotected in mother liquor containing 10%(v/v) glycerol before flash-cooling with liquid nitrogen.
Data collection and processing
Single-crystal diffraction data were collected at Station G in Sector 21 (LS-CAT) of the Advanced Photo Source at Argonne National Laboratory. The data were indexed, integrated and scaled using HKL-2000 (HKL Research). Details of diffraction and data reduction can be found in Table 2 . Windsor & Raines HIV-1 protease with phage-display-optimized substrate 691 Table 1 Endogenous and optimized HIV-1 protease substrate sequences.
Structure solution and refinement
Residues in bold are shared with the substrate identified by phage display. Oliveira et al. (2003) . of constraining alternative conformations of some residues simultaneously with other residues that occupy subsites fully (i.e. 1.0), occupancies were set manually. The residues in conformation A with alternative conformations were assigned an occupancy of 0.4 (conformation C), with the original conformer retaining 0.2 of the total occupancy (0.6) of conformation A. Details of refinement and the statistics of the final model are listed in Table 2 .
Results and discussion
SGIFLETS binds in alternative orientations
Unlike in analogous complexes, the substrate in the D25N HIV-1 protease-SGIFLETS complex lies in two antiparallel orientations ( Figs. 2a and 2b) . These orientations are not of equal occupancy (0.6 and 0.4 for A and B, respectively). Chemical symmetry (Table 1) of the residues in the P3 through P3 0 positions and a serine residue at both the P4 and the P4 0 positions are characteristics of SGIFLETS that could have led to this redundancy. Moreover, the protease flaps in the complex with SGIFLETS are in a previously unreported conformation in which a bridging water molecule (wat254) accepts hydrogen bonds from the main-chain amides of both Ile50 and Gly51, which are residues in the flaps. In other HIV-1 protease structures an intersubunit hydrogen bond forms between the main-chain atoms of Ile50 and Gly51. Despite unique interactions with its side chains, SGIFLETS is recognized by the protease through conserved interactions (Fig. 2c) .
3.2. Ser1A and Gly2A at the P4 and P3 positions occupy alternative conformations
Beck and coworkers used directed evolution (i.e. phage display) with the intent of diversifying the P3 to P3 0 residues (Beck et al., 2000) . Instead, they found that the residues of SGIFLETS varied in the P2 to P4 0 positions. Beck coworkers postulated that a marked preference for serine in the P4 position led to a high frequency of serine and glycine at the P4 and P3 positions in the selected substrates. Yet, both of these residues occupy alternative conformations in the major substrate orientation (conformation A) of the protease-SGIFLETS structure. Few endogenous substrates exhibit alternative binding modes for P3 and P4 residues (Prabu-Jeyabalan et al., 2002; Liu et al., 2011) . Unlike the conserved recognition strategy, in which the side chain of Asp29 accepts a hydrogen bond from the P3 main-chain NH and the NH of Gly48 donates a hydrogen bond to the P4 main-chain carbonyl O atom (Fig. 3a) , the P3/P4 amide of the p1/p6 substrate interacts with the carbonyl O atom of Gly48 and the side-chain N 2 H of Arg8 (Fig. 3b) . The protease-SGIFLETS complex employs both recognition strategies (in conformations A/B and C). Although found in opposite orientations relative to the protease, conformations A and B of Ser1 and Gly2 share the conserved -sheet mode of main-chain recognition, with the side-chain hydroxyl group of Ser1A/B forming a unique hydrogen bond to Lys45 in the protease flap (Fig. 3c ). The alternative conformer (conformation C) of the major orientation is reminiscent of the alternative recognition mode observed in the p1/p6 complex, with Ser1C instead forming a unique hydrogen bond to the carbonyl O atom of Gly49 (Fig. 3d ). Alternative recognition of the P4 main-chain carbonyl group by p1/p6 and selected substrates occurs through both direct and water-mediated interactions with Arg8. The unique hydrogen bonding exhibited by Ser1 provides a structural explanation for the preference for serine and glycine at the P4 and P3 positions.
The tips of the protease flaps were also resolved in a previously unreported interaction in which a bridging water molecule accepts hydrogen bonds from the main-chain NH of both Ile50 and Gly51 (Fig. 3d ). The occupancy of this novel water bridge correlates with the previously unreported hydrogen bond between the side chain of Ser1C and the carbonyl O atom of Gly49B. Rotation of Gly49B to accept the hydrogen bond appears to move the tip of the flap into a conformation that is incompatible with the inter-flap hydrogen bond, thus enabling water-bridge formation.
Glu6 and Ser8 form a network of hydrogen bonds
Weber and coworkers identified hydrogen bonds between the side-chain carboxyl group of a glutamic acid residue at position P2 0 of the CA/p2 substrate and the side chain of Asp30 of the protease (Weber et al., 1997) . This interaction is also apparent in the protease-SGIFLETS complex (Fig. 4a) . Given the pH of 5 at which these crystals were grown, a plausible explanation for the interatomic distance of 2.7 Å between O "1 of Glu6 (P2 0 ) and O 2 of Asp30 (chain A) is the formation of an intra-residue hydrogen bond (Fig. 4b) . Such a hydrogen bond is consistent with the substantial increases in the Michaelis constant (K m ) of the peptide substrate and the inhibition constant (K i ) of an analogous inhibitor upon increasing the pH from 5.6 to 6.7 (Beck et al., 2000) . The different interatomic distances (2.7 and 3.3 Å ) between O "1 and O "2 of Glu6 and O 2 of Asp30 suggest a single hydrogen bond to the proximal O atom and not a bifurcated hydrogen bond (Feldblum & Arkin, 2014) .
The serine residues at P4/P4 0 also form hydrogen bonds to the carboxyl group of Asp30 (Fig. 4a ). Few polar interactions have been revealed between Asp30 and residues in the P4/P4 0 positions, including arginine and serine. Neither of these interactions occur alongside a P2/P2 0 -interacting side chain Alternative conformations of P3 and P4 residues. Protease residues from chain A are shown in white, those from chain B in gray and substrates in black. (a) The CA/p2 complex (PDB entry 1f7a). Ala2 (P4) and Arg3 (P3) form -sheet-like interchain hydrogen bonds to Asp29 and Gly48. (b) The p1/p6 complex (PDB entry 1kjf). Gly48 and Arg8 alternatively recognize the P3/P4 amide. (c) The alternative orientations A and B of SGIFLETS exhibit the conserved -sheet conformation and a unique hydrogen bond between the side chains of Ser1A/B (P4) and Lys45. (d) Alternative conformation C is similar to that in (b) and has a unique hydrogen bond between the side-chain hydroxyl group of Ser1C (P4) and the main-chain O atom of Gly49. (Fig. 4b) . In the -strand conformation of bound substrates, the side chains of adjacent residues (iÁ Á Ái + 1) are farther from each other than are the side chains of two residues with an intervening residue (iÁ Á Ái + 2) (Ridky et al., 1996) . Bulky groups can lead to a steric clash between side chains and only spatially compatible amino acids are found at the i and i + 2 positions. The structure of the protease-SGIFLETS complex reveals the interdependence of P2 0 and P4 0 residues where, in addition to sterics, the identity of the residue is constrained by donor-acceptor interactions.
Thr7 plays a limited role
Endogenous protease substrates employ 2-5 polar residues in the core recognition sequence. Yet, only some of these side chains participate in hydrogen bonds, with an average utilization of about 60% (Ö zen et al., 2011) . In the protease-SGIFLETS complex three of the four polar side chains of SGIFLETS form hydrogen bonds. The exception is Thr7. The protease buries little of the P3/P3 0 side chain, leaving residues in this position largely exposed to solvent. Although threonine is a residue in the P3 0 position of HIV-1 protease substrates identified by phage display (Beck et al., 2000) , this position seems to have a limited role in substrate specificity (Tö zsé r et al., 1992) and could be a site for further optimization.
Conclusion
The endogenous substrates of HIV-1 protease represent only a small subset of sequences that can be cleaved by the enzyme.
Among the best of the known substrates, SGIFLETS, was derived by phage display. Its structure bound to the protease reveals the formation of many hydrogen bonds to its glutamic acid and serine side chains. Thus, hydrogen-bond formation could serve as a basis for the design of optimal substrates and perhaps of inhibitors of HIV-1 protease.
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